Kura Oncology, Inc.
$11.20
Market Cap
$1.01B
Shares Outstanding
89.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Aug 25, 2015
Round Lot
100
Locale
US
Day Open
$11.31
Day High
$11.52
Day Low
$11.14
Volume
1.79M
VWAP
$11.29
Prev Close
$11.30
Transactions
--
Acc. Volume
--
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
Kura Oncology, Inc. (KURA) closed the 2026-09-16 session at $11.20, down 0.88% versus the previous close (-0.10). The stock opened at $11.31 and traded between $11.14 and $11.52 during that session. Session trading volume was 1.8M shares. The volume-weighted average price (VWAP) is $11.29.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
Kura Oncology, Inc. has a market capitalization of $1.01 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. KURA is listed on the XNAS exchange. The company employs approximately 260 people. Kura Oncology, Inc. is headquartered in SAN DIEGO, CA. The recorded listing date is 2015-08-25.
On this page you can find market KURA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.